We are live on
!
Find out more
TI
tru Independence Portfolio holdings
AUM
$202M
1-Year Est. Return
15.81%
This Fund
S&P 500
This Quarter
Est. Return
+16.99%
1 Year Est. Return
+15.81%
3 Year Est. Return
+42.5%
5 Year Est. Return
+46.34%
10 Year Est. Return
–
AUM
$691K
AUM Growth
+$78K
(+13%)
Cap. Flow
+$226M
Cap. Flow
% of AUM
32,646.26%
Top 10 Holdings %
Top 10 Hldgs %
41.04%
Holding
960
New
207
Increased
181
Reduced
170
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$61.5M |
| 2 |
Schwab US Broad Market ETF
SCHB
|
+$54.4M |
| 3 |
iShares Core S&P US Growth ETF
IUSG
|
+$28.9M |
| 4 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$16.7M |
| 5 |
SPDR Gold Trust
GLD
|
+$9.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$10.7M |
| 2 |
General Mills
GIS
|
+$5.39M |
| 3 |
Microsoft
MSFT
|
+$3.32M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$3.24M |
| 5 |
Energizer
ENR
|
+$2.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 28.66% |
| 2 | Technology | 9.15% |
| 3 | Healthcare | 7.9% |
| 4 | Financials | 6.09% |
| 5 | Consumer Discretionary | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Martin Marietta Materials
MLM
$33.8B
| $1.14K | 0.16% |
+5,518
| New | +$1.06M |
|
102
Philip Morris
PM
$301B
| $1.13K | 0.16% |
16,070
+1,201
| +8% | +$87.6K |
|
103
First Trust Emerging Markets Small Cap AlphaDEX Fund
FEMS
$249M
| $1.12K | 0.16% |
+44,385
| New | +$1.3M |
|
104
Revvity
RVTY
$12.3B
| $1.11K | 0.16% |
+11,314
| New | +$1.03M |
|
105
AbbVie
ABBV
$450B
| $1.09K | 0.16% |
11,129
-2,747
| -20% | -$242K |
|
106
DuPont de Nemours
DD
$18.3B
| $1.09K | 0.16% |
16,363
-10,037
| -38% | -$586K |
|
107
British American Tobacco
BTI
$136B
| $1.07K | 0.16% |
27,674
-500
| -2% | -$19.2K |
|
108
GoDaddy
GDDY
$12.5B
| $1.05K | 0.15% |
+14,361
| New | +$1.03M |
|
109
Abbott
ABT
$175B
| $1.03K | 0.15% |
11,312
+609
| +6% | +$55K |
|
110
Capital One
COF
$128B
| $1.01K | 0.15% |
16,211
-301
| -2% | -$18.7K |
|
111
Honeywell
HON
$71.3B
| $998 | 0.14% |
7,322
-45
| -0.6% | -$5.96K |
|
112
Procter & Gamble
PG
$349B
| $991 | 0.14% |
8,284
-1,452
| -15% | -$169K |
|
113
SS&C Technologies
SSNC
$16.8B
| $978 | 0.14% |
+17,320
| New | +$944K |
|
114
Walt Disney
DIS
$170B
| $976 | 0.14% |
8,748
+35
| +0.4% | +$3.86K |
|
115
Accenture
ACN
$87.9B
| $961 | 0.14% |
4,475
+54
| +1% | +$10.2K |
|
116
Jacobs Solutions
J
$15.6B
| $955 | 0.14% |
+13,611
| New | +$918K |
|
117
ProShares Short S&P500
SH
$884M
| $934 | 0.14% |
5,043
+765
| +18% | +$73.5K |
|
118
Cincinnati Financial
CINF
$28B
| $904 | 0.13% |
14,129
+14,045
| +16,720% | +$927K |
|
119
SLB Ltd
SLB
$70.3B
| $887 | 0.13% |
48,218
-1,050
| -2% | -$18.4K |
|
120
Nike
NKE
$64.9B
| $869 | 0.13% |
8,863
-2,452
| -22% | -$226K |
|
121
iShares MSCI USA Min Vol Factor ETF
USMV
$23.1B
| $865 | 0.13% |
+14,274
| New | +$847K |
|
|
EVBG
122
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $858 | 0.12% |
+6,202
| New | +$806K |
|
123
Amphenol
APH
$186B
| $855 | 0.12% |
+35,708
| New | +$797K |
|
124
American International
AIG
$42.7B
| $845 | 0.12% |
27,224
-896
| -3% | -$25.2K |
|
|
PARA
125
DELISTED
Paramount Global Class B
PARA
| $837 | 0.12% |
35,876
-4,030
| -10% | -$77.7K |
|
Similar funds
4FG
BFA
GDADCM
PCMK
CWM
AFWM
HWMO
PCM
tru Independence's Q2 2020 Portfolio in Review
As of Q2 2020, tru Independence held 960 positions worth $691K, up 13% from $613K the previous quarter. Its ten largest holdings account for 41% of the portfolio.
tru Independence deployed $226M of net new capital in Q2 2020, opening 207 new positions and adding to 181 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,027,572 shares worth $19.
By sector, the portfolio is most concentrated in Energy at 29% of assets, up from 2.7% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was First Trust NYSE Arca Biotechnology Index Fund, an estimated $10.7M trimmed.
- tru Independence's largest Q2 2020 buy was Bristol-Myers Squibb: 1,027,572 shares worth $19.
- tru Independence added most to SPDR Gold Trust in Q2 2020, an estimated $9.38M increase.
- tru Independence's biggest Q2 2020 reduction was First Trust NYSE Arca Biotechnology Index Fund, cutting an estimated $10.7M.
- tru Independence fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020, selling an estimated $49.3K.
- tru Independence's ten largest holdings make up 41% of its $691K portfolio in Q2 2020.
- tru Independence opened 207 new positions and closed 53 in Q2 2020.
- tru Independence's portfolio value rose 13% quarter-over-quarter to $691K.
Based on tru Independence's 13F filing for Q2 2020, filed 19 Aug 2020.